Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Topic

May 19, 2016

The O’Neill Report is the British Government’s response to tackling the emerging antibiotic resistance crisis. In order to overcome this global threat, all countries must play their part and take action to address the crisis, including funding research and development for new tools—new classes of antibiotics, but also diagnostics and vaccines—while ensuring sustainable and affordable access for those new tools. At the same time, steps need to be taken to conserve existing antibiotics for as long as possible.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

April 08, 2016

New York/Lusaka, Zambia—The largest cholera vaccination campaign ever began today in Zambia’s capital, Lusaka. International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is working in close collaboration with the Zambian Ministry of Health and the World Health Organization to vaccinate more than half a million people in the next two weeks to curb the outbreak that began in February in the city’s overcrowded township areas.

March 29, 2016

MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could prevent millions of people from accessing lifesaving medicines

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

February 22, 2016

As the rainy season approaches in Wajir, northeastern Kenya, Doctors Without Borders/Médecins Sans Frontières (MSF) warns that the substandard water and sanitation situation is creating ideal conditions for a future increase in cholera cases. While today patient numbers in the cholera treatment center in Wajir Hospital are stable, MSF urges for an immediate improvement in sanitation services to avoid another spike in cases.

January 25, 2016

Five diseases with the potential to become epidemics in 2016 are being highlighted by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF), as the World Health Organization’s executive board meets in Geneva this week.

December 02, 2015

GENEVA/CAPE TOWNDoctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership today released the second edition of the Out of Step report, a 24-country survey of policies and practices used today to guide the diagnosis and treatment of tuberculosis (TB).

September 17, 2015

ABUJA, NIGERIA/PARIS—A cholera outbreak is underway in camps for people displaced by the conflict with Boko Haram in Nigeria's Borno state, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, calling for other humanitarian organizations to join the ef

Pages